TER
0.30% p.a.
Distribution policy
Accumulating
Replication
Physical
Fund size
GBP 3 m
Holdings
98
Advertisement
Overview
GBP 21.72
28/03/2025 (XETRA)
-0.35|-1.59%
daily change
52 weeks low/high
21.72
25.16
Description
The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C seeks to track the MSCI ACWI IMI Genomic Innovation Select Screened 100 index. The MSCI ACWI IMI Genomic Innovation Select Screened 100 index tracks stocks from developed and emerging countries worldwide. The index selects companies that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance). The parent index is the MSCI ACWI IMI.
Documents
Basics
Data
| Index | MSCI ACWI IMI Genomic Innovation Select Screened 100 |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | GBP 3 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 16.58% |
| Inception/ Listing Date | 12 July 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Xtrackers |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
Similar ETFs
This section provides you with information on other ETFs with a similar investment focus to the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our ETF profile? Here you'll find our Questionnaire.
Holdings
Below you find information about the composition of the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C.
Top 10 Holdings
Weight of top 10 holdings
out of 98
46.07%
| Agilent Technologies | 4.91% |
| Natera | 4.80% |
| Abbott Laboratories | 4.79% |
| Bristol Myers Squibb Co. | 4.71% |
| Thermo Fisher Scientific, Inc. | 4.71% |
| Danaher Corp. | 4.67% |
| Lonza Group AG | 4.60% |
| Illumina, Inc. | 4.49% |
| Roche Holding AG | 4.43% |
| Vertex Pharmaceuticals | 3.96% |
Countries
| United States | 77.96% |
| Switzerland | 10.05% |
| China | 3.16% |
| Other | 8.83% |
Sectors
| Health Care | 94.36% |
| Other | 5.64% |
As of 31/12/2024
Performance
Returns overview
| YTD | -6.18% |
| 1 month | -5.77% |
| 3 months | -6.82% |
| 6 months | -8.16% |
| 1 year | -10.25% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | -21.39% |
| 2024 | -0.77% |
| 2023 | -8.94% |
| 2022 | - |
| 2021 | - |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 16.58% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.62 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -13.67% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -30.08% |
Rolling 1 year volatility
Stock exchange
Listings
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XGEN | - - | - - | - |
| Borsa Italiana | EUR | XGEN | XGEN IM XGENEUIV | XGEN.MI XGENEURINAV=SOLA | |
| London Stock Exchange | USD | XGEN | XGEN LN XGENUSIV | XGEN.L XGENUSDINAV=SOLA | |
| London Stock Exchange | GBP | XGES | XGES LN XGENCHIV | XGES.L XGENCHFINAV=SOLA | |
| SIX Swiss Exchange | CHF | XGEN | XGEN SW XGENGBIV | XGEN.S XGENGBPINAV=SOLA | |
| XETRA | EUR | XGEN | XGEN GR | XGEN.DE |
Further information
Further ETFs with similar investment focus
Frequently asked questions
What is the name of XGES?
The name of XGES is Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C.
What is the ticker of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The primary ticker of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is XGES.
What is the ISIN of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The ISIN of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is IE000KD0BZ68.
What are the costs of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The total expense ratio (TER) of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C amounts to 0.30% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C paying dividends?
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C?
The fund size of Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is 3m GBP. See the following article for more information about the size of ETFs.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
- Last 30 Days
- Current Month
- Last Month
- YTD
- 1 year
- 3 years
- 5 years
- Custom Range
